AYTU
Aytu BioPharma·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
AYTU Filings
Filing Date
Form Description
Form Type
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-13
Aytu BioPharma, Inc. (AYTU) Q1 2026 Earnings Call Transcript
Earnings Call
2025-11-13 · Earnings Call
Aytu BioPharma, Inc. (AYTU) Q1 2026 Earnings Call Transcript
2025-11-13
Form 8-K - Current report
Key Events
2025-11-13 · Key Events
Form 8-K - Current report
2025-11-13
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-13 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-12
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-12 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-10-24
Form ARS - Annual Report to Security Holders
2025-10-24 ·
Form ARS - Annual Report to Security Holders
2025-10-24
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Key Events
2025-10-24 · Key Events
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
2025-10-24
Form DEF 14A - Other definitive proxy statements
Key Events
2025-10-24 · Key Events
Form DEF 14A - Other definitive proxy statements
2025-10-20
Form 5 - Annual statement of changes in beneficial ownership of securities
Ownership
2025-10-20 · Ownership
Form 5 - Annual statement of changes in beneficial ownership of securities
2025-10-07
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-10-07 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
